Related Experiment Video
Updated: May 11, 2026
12:44
Identification of Key Factors Regulating Self-renewal and Differentiation in EML Hematopoietic Precursor Cells by RNA-sequencing Analysis
Published on: November 11, 2014
Targeting self-renewal pathways in myeloid malignancies
William A Sands1, Mhairi Copland, Helen Wheadon
1Paul O'Gorman Leukaemia Research Centre, College of Medical, Veterinary and Life Sciences, University of Glasgow, Gartnavel General Hospital, 1053 Great Western Road, Glasgow G12 0ZD, UK. Helen.Wheadon@glasgow.ac.uk.
Cell Communication and Signaling : CCS
|May 17, 2013
Summary
Hematopoietic stem cells (HSCs) self-renewal is regulated by complex signaling pathways. Understanding these pathways
Area of Science:
- Hematology
- Stem Cell Biology
- Molecular Biology
Background:
- Hematopoietic stem cells (HSCs) possess the critical ability to self-renew, a process vital for maintaining blood cell production.
- Self-renewal is tightly regulated by intricate signal transduction cascades and transcriptional networks that balance stem cell maintenance and differentiation.
- The bone marrow niche microenvironment provides essential signals, including chemokines, cytokines, and morphogens, that influence HSC behavior through paracrine and autocrine mechanisms.
Purpose of the Study:
- To elucidate the cross-talk between signaling pathways that govern HSC self-renewal.
- To identify potential therapeutic targets for preventing leukemic stem cell self-renewal in myeloid malignancies.
Main Methods:
- Review and synthesis of current literature on HSC self-renewal signaling pathways.
- Analysis of convergent points and redundancies in downstream signaling cascades.
- Identification of therapeutic windows within these pathways.
Main Results:
- Multiple signaling pathways converge to regulate HSC self-renewal, offering redundancy in normal hematopoiesis.
- Cross-talk between these pathways is crucial for maintaining the delicate balance of stem cell behavior.
- Specific signaling nodes represent potential targets for therapeutic intervention.
Conclusions:
- Targeting the cross-talk of signaling pathways offers a promising strategy to inhibit aberrant HSC self-renewal in myeloid cancers.
- Understanding these regulatory mechanisms can lead to novel treatments for leukemic stem cells.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:19Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...